Le Lézard
Classified in: Health
Subject: AWD

spencer® technology recognized in Frost & Sullivan 2018 North American Enabling Technology Leadership Award


MORRISVILLE, N.C., Dec. 12, 2018 /PRNewswire/ -- The spencer medication dispenser, as featured within the Philips Medication Adherence Solution (PMAS), was lauded by Frost & Sullivan for creating an ecosystem that connects patients, pharmacists, providers and caregivers on a single platform, making it a vastly superior solution to mere pill dispensing devices.

spencer Health Solutions, Inc. logo (PRNewsfoto/spencer Health Solutions)

"It is especially gratifying for spencer technology to be recognized as the enabling technology of the Philips Medication Adherence Solution," said Tom Rhoads, CEO of spencer Health Solutions, Inc. "Spencer already is making a difference in the lives of complex patients, and this market validation is timely as we introduce our unique engagement technology to clinical research, where real-time insights can speed the delivery of new treatment options."

The annual award also recognizes high market acceptance potential of the technology. Based on its recent analysis of the North American medication adherence market, Frost & Sullivan recognized Philips, a global leader in health technology, with the 2018 North American Enabling Technology Leadership Award for creating a connected ecosystem that allows payers and providers to track their patients' health.

Divyaa Ravishankar, Frost & Sullivan Industry Principal, said: "It (spencer®) is designed with a patient-friendly interface, as well as an alert system and connected app that offers timely notifications for pharmacists and clinicians if a patient misses a dose. With its remote patient monitoring capability, digital tools, and door-to-door delivery, the company has innovated the caregiving pathway from hospital to home."

The World Health Organization (WHO) requires a patient's compliance to be at 80 percent, while patients using spencer have an adherence level of 98 percent. Additionally, the current engagement rate among spencer patients is 82 percent based on the frequency of their response to health-related questions presented with each medication dose.

Providers contracted by Philips offer PMAS units to their patients at no direct cost, and every spencer®-certified pharmacist verifies coverage details before transferring and packaging prescriptions to the device. The spencer in-home connected device dispenses medications with dose-level adherence reporting and passively captures biometric data (glucose levels, blood pressure). It also enables patient-reported questions and answers, telehealth with video healthcare team appointments, and connects to the spencerAssist® mobile app.

Within the care management market, spencer Health Solutions has partnerships with leading technology distributors in the U.S., Canada and Europe.

About spencer Health Solutions: spencer Health Solutions, Inc. creates intuitive technology to help people manage their health as they contribute to drug discovery. The North Carolina company's award-winning spencer® medication dispensing, telehealth and engagement platform extends access, and enables virtual care by making it simple for patients, their health care providers, and clinical research teams to stay connected.

For more information, visit www.helloimspencer.com

Media Contact:  Gayle McCracken

[email protected], +1.919.208.9176

SOURCE spencer Health Solutions


These press releases may also interest you

at 17:00
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...

at 16:42
Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its Annual Report on Form 20-F for the fiscal year ended December 31,...

at 16:27
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Thursday, the FDA posted a safety communication to inform the public and healthcare providers that the agency has required and...

at 16:19
Unifor expects to achieve the wage increases and benefit improvements awarded to Ontario OCHU-CUPE and SEIU Healthcare members by Arbitrator William Kaplan in a recent decision....

at 16:10
Acadia Pharmaceuticals Inc. today announced that on April 10, 2024, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common...

at 16:10
Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its previously announced public offering of 15,197,500 shares of common stock (or pre-funded...



News published on and distributed by: